Dr. Nagla Abdel Karim, MD, PhD

Media Releases

Innovative Oncologist Brings Over Three Decades of Expertise to Inova Schar Cancer Institute

Fairfax, Virginia – Inova Schar Cancer Institute proudly announces the continued leadership of Nagla Abdel Karim, MD, PhD, a board-certified medical oncologist with over three decades of experience in cancer care and treatment. As the Director of the Phase I Program at the Inova Schar Cancer Institute and a Professor of Medicine in the Division of Hematology/Oncology at the University of Virginia, Dr. Karim is at the forefront of personalized cancer therapy, particularly for patients with lung cancer.

Her clinical and research endeavors focus on Phase I clinical trials, where she utilizes innovative approaches to tailor therapies for patients. Dr. Karim serves as the Study Chair for the S1929 clinical trial at SWOG, which is dedicated to exploring personalized treatment options for patients with SLFN11 small cell lung cancer. Her commitment to advancing cancer care through research exemplifies her dedication to improving patient outcomes.

Dr. Karim earned her Medical Degree from the University of Cairo- Faculty of Medicine in 1993 and completed her training in internal medicine and medical oncology at the National Cancer Institute in Cairo. She further pursued her academic journey by obtaining a Master of Science Degree and a Doctor of Philosophy Degree – the latter of which she obtained through a channel program with the University of Washington.

Dr. Karim’s post-doctoral fellowship at MD Anderson in Cancer Prevention and subsequent research fellowship at the University of Washington laid the foundation for her distinguished career. After completing her residency in internal medicine at Fairview-Cleveland Clinic Hospitals in Ohio, she joined the University of Cincinnati as an Assistant Professor of Medicine. She later served as an Associate Professor until 2018. 

From 2018 to 2022, Dr. Karim held the position of Professor of Medicine and Director of Thoracic Oncology at the Medical College of Georgia, where she led numerous clinical trials and translational research projects. She is a Diplomate of the American Board of Internal Medicine, reflecting her commitment to maintaining the highest standards in patient care.

Dr. Karim’s leadership at Inova Schar Cancer Institute signifies a pivotal advancement in the fight against cancer, as she continues to explore groundbreaking methods to personalize treatment for her patients. Through her extensive experience and dedication, Dr. Nagla Abdel Karim is poised to make significant contributions to the field of oncology and improve the lives of those affected by cancer. 

Recommended Articles

• Know the Symptoms of Colon Cancer

  In order to recognize if you have colon cancer, it is vital to know the signs and symptoms of colon cancer. However, most of the symptoms caused by a carcinoma of the colon can also be seen with other diseases that isn’t a cancer, such as hemorrhoids, irritable bowel syndrome, and infections of...

• How Are the Treatment Options for Leukemia Managed?

  Leukemia is a group of different cancers of the blood. Unlike other types of cancers, leukemia has the unique feature of not having a detectable tumor or malignant mass, which is typical of other types of cancer. In leukemia, the cancer cells are found in the blood and bone marrow. The abnormally...

• Breast Cancer Risk Could Depend on a Combination of Gene Variation and Environment

  A recent topic for many people concerned about breast cancer is the genetic factors involved. Genetics is a confusing topic for many people because it can be hard to determine the exact risk of getting a disease. While we know that genetics is a factor, the specific genes that cause cancer have been...

• What Is Colorectal Cancer?

  Cancer of the tissue in the colon or rectum is referred to as colorectal cancer. Cancer arises due to the abnormal growth and division of tissues in one of these organs. The uncontrolled division and growth of the cells in the colon or rectum result in the formation of a tumor. This cancer has a...

• Treatment Options for Bladder Cancer

  Treatment Options for Bladder CancerFor a doctor to decide the best treatment for your bladder cancer, he or she has to look at the progression of the disease and what stage it's at. As stages of bladder cancer are very crucial before making treatment decisions, your doctor will perform different...

• Breastfeeding Can Lower the Risk of Ovarian Cancer

  If you are pregnant and at risk for ovarian cancer, consider breastfeeding your baby to greatly reduce your risk. The idea that breastfeeding reduces a woman’s risk for disease is not new. However, it is still widely unadvertised, so many women are still unaware of the other benefits of...